Clinical Trial Update: Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program

View source ↗

Summary

The Piedmont Healthcare–sponsored clinical trial evaluating an individualized comprehensive atherosclerosis risk-reduction program has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: Piedmont Healthcare | Conditions: Atherosclerosis | Status: COMPLETED